Letter: Vitamin D Deficiency and Autoimmune Hepatitis – from Research to Treatment

Jiamei Wang,Jianjiang Xu,Xiaoping Shao,Zonggui Wu,Chun Liang

DOI: https://doi.org/10.1111/apt.15147

IF: 9.524

2019-01-01

Alimentary Pharmacology & Therapeutics

Abstract:Linked Content This article is linked to Ebadi et al papers. To view these articles, visit https://doi.org/10.1111/apt.15029 and https://doi.org/10.1111/apt.15154 .

What problem does this paper attempt to address?

Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?

Chao-Nan Jin,Jing-Dan Chen,Ji-Fang Sheng

DOI: https://doi.org/10.1097/MEG.0000000000001134

2018-01-01

European Journal of Gastroenterology & Hepatology

Abstract:In the past few years, a growing body of clinical evidence has highlighted the risk of vitamin D deficiency in patients with chronic hepatitis C and that vitamin D levels are associated with the course of hepatitis C virus (HCV) infection, adverse effects, and treatment response to peginterferon/ribavirin. Recently, studies have found that vitamin D status is related to drug resistance and increased risk of infection in patients with liver cirrhosis. Vitamin D-related gene polymorphisms have been found to explain the interactions between vitamin D deficiency and HCV infection, offering a new perspective toward understanding the current problems such as the development of insulin resistance and racial differences in sustained virological response. Studies have been conducted to determine whether vitamin D supplementation as an adjuvant yields a better result compared with traditional HCV treatment. Here, we provide a brief review of the past and present knowledge of vitamin D in HCV infection.
Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective

Yassine Kilani,Saqr Alsakarneh,Mahmoud Y. Madi,Daniel Alejandro Gonzalez Mosquera,Mariana Nunes Ferreira,Fouad Jaber,John Helzberg,Nikki Duong,Wing‐Kin Syn

DOI: https://doi.org/10.1111/apt.18438

IF: 9.524

2024-12-13

Alimentary Pharmacology & Therapeutics

Abstract:Our study provides real‐world evidence showing a significant association between vitamin D deficiency and elevated rates of liver‐specific complications—including decompensated cirrhosis, acute hepatic failure and liver transplant—as well as increased all‐cause hospitalizations, and all‐cause mortality among individuals with autoimmune hepatitis. Background Vitamin D deficiency is linked to worse outcomes in patients with chronic liver diseases (CLD). However, data in patients with autoimmune hepatitis (AIH) remain limited. Aims We aimed to assess the impact of vitamin D deficiency on the outcomes of individuals with AIH. Methods This retrospective cohort study used the TriNetX research network to identify patients with AIH. Patients were matched using propensity score matching and stratified to sufficient vitamin D levels (e.g., 25 (OH) D3 ≥ 30 ng/mL), vitamin D insufficiency (25 (OH) D3: 20–29.9 ng/mL) and vitamin D deficiency (e.g., 25 (OH) D3

pharmacology & pharmacy,gastroenterology & hepatology
The relationship between 25 hydroxyvitamin D level and chronic hepatitis C: a Meta-analysis

Fangzhou JIAO,Haiyue ZHANG,Wenbin ZHANG,Zuojiong GONG

DOI: https://doi.org/10.3969/j.issn.1671-6450.2017.08.018

2017-01-01

Abstract:Objective To review the relationships between 25 hydroxyvitamin D3[25(OH)D3]levels and chronic hepatitis C.Methods We searched Cochrane Library,Medline,PubMed,Chinese Biomedical Literature Database(CBM),VIP,CNKI,and Wanfang database of English and Chinese studies reporting the relationship between 25 hydroxyvitamin D levels and chronic hepatitis D form establish of the database to March 1,2017.Results Twelve studies(n=1 144)were finally included,737 cases in CHC group and 407 in control group.The results of meta-analysis showed that 25(OH)D3 in patients with CHC was lower than the control group individuals(SMD=-1.59,95％CI-2.37～-0.80,P<0.01).The subgroup analysis of ethnicity,the CHC group was lower than the control group in the serum 25(OH)D3 levels for both Asian and Egyptian(SMD=-2.48,95％CI-3.58～-1.38,P<0.01;SMD=-2.10,95％CI-3.23～-0.96,P<0.01),while there was no statistical difference for White(SMD=-0.20,95％CI-1.42～-1.03,P=0.75).In the subgroup analysis of detection method for 25(OH)D3,both of ELISA and chromatography showed that the serum 25(OH)D3 levels in CHC group was lower than the control group(SMD=-2.39,95％CI-3.22～-1.56,P<0.01;SMD=-1.75,95％CI-2.06～-1.44,P<0.01).The result of the study showed no bias and reliable according to publication bias analysis and sensitivity analysis.Conclusion The 25 hydroxyvitamin D level was lower in chronic hepatitis C patients than health control.Due to the small of sample sizes,more high quality,large sample studies are needed to verify the results.
Letter: Autoimmune hepatitis and metabolic syndrome‐associated disease development – a US cohort study

Liling Deng,Wuquan Deng

DOI: https://doi.org/10.1111/apt.17231

2022-01-01

Abstract:LINKED CONTENT This article is linked to Jalal et al papers. To view these articles, visit
Potential Role of Vitamin D in Immune Response in Patients with Viral Hepatitis.

Catharina Gerhards,Andreas Teufel,Marlis Gerigk,Michael French,Christoph Antoni,Matthias Ebert,Michael Neumaier,Osman Evliyaoglu

DOI: https://doi.org/10.1016/j.nut.2024.112447

IF: 4.893

2024-04-01

Nutrition

Abstract:Background To study the relationship of Vitamin D with innate and adaptive immune response parameters in chronic hepatitis B and C patients. Methods The laboratory data between 01.01.2013-01.01.2023 for patients with chronic hepatitis B (CHB), and chronic hepatitis C (CHC) were extracted. Serum 25-hydroxyl vitamin D, hepatitis B virus serological markers, complements, and subsets of T lymphocytes were determined. Study cohorts were divided into groups based on serum 25-hydroxyl vitamin D levels with further evaluation of laboratory data. Results In CHB and CHC patients the percentage of CD4+ T lymphocytes and the CD4+/CD8+ ratio significantly decreased (p < 0.05), but the percentage of CD8+ increased (p < 0.05) compared to the control group. In CHB patients Vitamin D decrease was significant (p < 0.001) but not in CHC patients. Vitamin D showed a moderate negative influence on the CD8 cell count in CHB patients. The positive ratio of HBV DNA and HBsAg decreased with increasing serum vitamin D levels. The vitamin D deficient group showed significantly lower antibody production compared to the normal group, and exhibited significantly decreased CD4 numbers and increased CD8 numbers (p < 0.05 and p < 0.001, respectively), while the CD4/CD8 ratio was also significantly decreased in the insufficiency group (p < 0.001). Complement C3 levels were not associated with CD4 and CD8, but had an inverse relation with Vitamin D. Vitamin D levels were significantly associated with complement C3, CD8+, CD4+, CD19+ cells, and HBV DNA levels. Conclusions Vitamin D may be a modulator of immune function not only via CD8+ and CD4+ cells but also via CD19+ cells in the course of chronic HBV infection. The negative relationship between vitamin D and complement C3 needs elucidation. Moreover, the increased proportion of B cells and decreased CD4+ cells in Vitamin D deficiency disrupt the immune response against HBV since the expected antibody response was not obtained despite the increase in B cell ratio. This indicates an influence of CD4+ cells for B cell functionality. In summary, sufficient levels of Vitamin D may lead to a sustained virological response that is debatable by artificially correcting the deficiency.

nutrition & dietetics
Vitamin D in liver diseases: from mechanisms to clinical trials.

Yuan-Ping Han,Ming Kong,Sujun Zheng,Yan Ren,Longdon Zhu,Hongbo Shi,Zhongping Duan

DOI: https://doi.org/10.1111/jgh.12016

2013-01-01

Journal of Gastroenterology and Hepatology

Abstract:Traditionally regarded as a typical vitamin regulating calcium and phosphorus homeostasis, vitamin D is now discovered as a highly versatile molecule with emerging roles in immunity, cancer, infectious diseases, fibrosis, fatty liver diseases, and alcoholic liver diseases. A large body of clinical evidence has demonstrated the prevalence and risks of vitamin D deficiency in various chronic diseases. Biologically active vitamin D, 1,25-dihydroxylvitamin D3, is synthesized in two distinct systems. In addition to the classic two-step hydroxylation in the liver and kidneys, 1,25-dihydroxylvitamin D3 can also be produced locally by immune cells in response to infection. The bioactive vitamin D generated in these two pools apparently functions differently: while the former facilitates calcium adsorption and homeostasis, the latter confers immune regulation. The immune regulatory functions of vitamin D are demonstrated by induction of antimicrobial peptides, suppression of innate immune response, induction of Th2 cytokines, and stimulation of T-regulatory T cells. Vitamin D deficiency or insufficiency is overwhelmingly associated with viral hepatitis, cirrhosis, and fatty liver diseases. Recent clinical trials have shown that vitamin D supplements significantly enhance the efficacy of interferon plus ribavirin therapy through sustained virological response. A recent study showed that 25-dihydroxyvitamin D rather than 1,25-dihydroxyvitamin D could directly suppress hepatitis C virus assembly. Moreover, clinical evidence has shown that vitamin D deficiency is associated with alcoholic and non-alcoholic fatty liver diseases. In this review, we highlight some recent advances in vitamin D researches and clinical trails.
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.

Rui Yu,Deming Tan,Qin Ning,Junqi Niu,Xuefan Bai,Shijun Chen,Jun Cheng,Yanyan Yu,Hao Wang,Min Xu,Guangfeng Shi,Mobin Wan,Xinyue Chen,Hong Tang,Jifang Sheng,Xiaoguang Dou,Junping Shi,Hong Ren,Maorong Wang,Hongfei Zhang,Zhiliang Gao,Chengwei Chen,Hong Ma,Jidong Jia,Jinlin Hou,Qing Xie,Jian Sun

DOI: https://doi.org/10.1111/hepr.12972

2018-01-01

Hepatology Research

Abstract:Aim: The role of vitamin D in individuals with chronic hepatitis B (CHB) is unclear. We aimed to explore the association of baseline vitamin D level with genetic determinants and week-104 treatment outcome in CHB patients. Methods: Baseline serum 25-hydroxycholecalciferol (25(OH)D) levels and genetic polymorphism within GC, DHCR7, and CYP2R1 were determined in stored serum of 560 patients who were enrolled into amulticenter, randomized, controlled study and completed 104 weeks of telbivudine monotherapy or telbivudine-based optimized therapy. Virologic response was defined as hepatitis B virus DNA <300 copies/mL (52 IU/mL) at week 104. Results: The mean 25(OH)D value was 29.64 ng/mL. The percentage of patients with vitamin D insufficiency (<30 ng/mL) and vitamin D deficiency (<20 ng/mL) were 55.0% and 20.9%, respectively. Gender, season, latitude, and GC rs2282679 polymorphism were independent factors of vitamin D status. Patients with sufficient vitamin D (>= 30 ng/mL) achieved a higher virologic response rate than those with vitamin D insufficiency (81.7% vs. 67.2%, P < 0.001). The area under the curve of 25(OH)D to predict virologic response was 0.65 (P < 0.001; 95% confidence interval, 0.62-0.67). On multivariate analysis, 25(OH)D level was an independent predictor of virologic response, but not associated with hepatitis B envelope antigen (HBeAg) seroconversion or alanine aminotransferase (ALT) normalization. Conclusions: Vitamin D insufficiency was highly prevalent in treatment-naive CHB patients in mainland China. Latitude and genetic determinants affect vitamin D status. Baseline vitamin D level can predict week-104 virologic response, but not HBeAg seroconversion or ALT normalization.
New Insight of Vitamin D in Chronic Liver Diseases

En-Qiang Chen,Ying Shi,Hong Tang

DOI: https://doi.org/10.1016/s1499-3872(14)60295-2

2014-01-01

Abstract:BACKGROUND: Vitamin D is a fat-soluble sterol derivative that is predominantly synthesized in the liver and has multiple functions. The accumulative data showed that the clinical manifestations and prognosis of chronic liver diseases are associated with serum vitamin D levels.DATA SOURCES: A PubM ed and Google Scholar search using terms: "vitamin D", "25（OH）D", "liver disease", "viral hepatitis", "non-alcoholic fatty liver disease", "liver fibrosis", "cirrhosis", "hepatocellular carcinoma" and "autoimmune liver disease" was performed, and relevant articles published in English between January 2000 and March 2014 were reviewed. Fulltext publications relevant to the field were selected and relevant articles from reference lists were also included. RESULTS: The insufficiency or deficiency of vitamin D is common in various kinds of chronic liver diseases including viral hepatitis B and C. Serum 25-hydroxyvitamin D and vitamin D receptors are possibly interrelated with the incidence,treatment and prognosis of diseases. Though the evidence of vitamin D supplementation in viral hepatitis and associated liver diseases is still limited, there is great potential to apply this adjuvant therapy to improve the treatments. CONCLUSIONS: Although the exact role and mechanisms of vitamin D have not been fully elucidated in chronic liver diseases, it is potentially beneficial in the treatment of chronic liver diseases. Further mechanistic studies are needed to validate its clinical application.
Vitamin D Receptor Targets Hepatocyte Nuclear Factor 4α and Mediates Protective Effects of Vitamin D in Nonalcoholic Fatty Liver Disease.

Hong Zhang,Zhe Shen,Yiming Lin,Jie Zhang,Yuwei Zhang,Peihao Liu,Hang Zeng,Mengli Yu,Xueyang Chen,Longgui Ning,Xinli Mao,Li Cen,Chaohui Yu,Chengfu Xu

DOI: https://doi.org/10.1074/jbc.ra119.011487

2020-01-01

Abstract:Epidemiological studies have suggested a link between vitamin D deficiency and increased risk for nonalcoholic fatty liver disease (NAFLD); however, the underlying mechanisms have remained unclear. Here, using both clinical samples and experimental rodent models along with several biochemical approaches, we explored the specific effects and mechanisms of vitamin D deficiency in NAFLD pathology. Serum vitamin D levels were significantly lower in individuals with NAFLD and in high-fat diet (HFD)-fed mice than in healthy controls and chow-fed mice, respectively. Vitamin D supplementation ameliorated HFD-induced hepatic steatosis and insulin resistance in mice. Hepatic expression of vitamin D receptor (VDR) was up-regulated in three models of NAFLD, including HFD-fed mice, methionine/choline-deficient diet (MCD)-fed mice, and genetically obese (ob/ob) mice. Liver-specific VDR deletion significantly exacerbated HFD- or MCD-induced hepatic steatosis and insulin resistance and also diminished the protective effect of vitamin D supplementation on NAFLD. Mechanistic experiments revealed that VDR interacted with hepatocyte nuclear factor 4 α (HNF4α) and that overexpression of HNF4α improved HFD-induced NAFLD and metabolic abnormalities in liver-specific VDR-knockout mice. These results suggest that vitamin D ameliorates NAFLD and metabolic abnormalities by activating hepatic VDR, leading to its interaction with HNF4α. Our findings highlight a potential value of using vitamin D for preventing and managing NAFLD by targeting VDR.
Autoimmune Thyroiditis and Vitamin D

Teodoro Durá-Travé,Fidel Gallinas-Victoriano

DOI: https://doi.org/10.3390/ijms25063154

IF: 5.6

2024-03-09

International Journal of Molecular Sciences

Abstract:Hashimoto's thyroiditis (HT) is marked by self-tissue destruction as a consequence of an alteration in the adaptive immune response that entails the evasion of immune regulation. Vitamin D carries out an immunomodulatory role that appears to promote immune tolerance. The aim of this study is to elaborate a narrative review of the relationship between vitamin D status and HT and the role of vitamin D supplementation in reducing HT risk by modulating the immune system. There is extensive literature confirming that vitamin D levels are significantly lower in HT patients compared to healthy people. On the other hand, after the supplementation with cholecalciferol in patients with HT and vitamin D deficiency, thyroid autoantibody titers decreased significantly. Further knowledge of the beneficial effects of vitamin D in the prevention and treatment of autoimmune thyroid diseases requires the execution of additional randomized, double-blind, placebo-controlled trials and longer follow-up periods.

biochemistry & molecular biology,chemistry, multidisciplinary
Letter: time to consider Pneumocystis jirovecii pneumonia prophylaxis in treatment of autoimmune hepatitis

Daniel Schneider,Alexander Strathmore,Catherine Yu,Nicholas Hannah,Siddharth Sood

DOI: https://doi.org/10.1111/apt.17508

2023-04-26

Abstract:Alimentary Pharmacology &Therapeutics, Volume 57, Issue 10, Page 1210-1211, May 2023.

pharmacology & pharmacy,gastroenterology & hepatology
Vitamin D serum levels and receptor genetic polymorphisms are associated with hepatitis B virus and HIV infections and IFN-λ levels

Wenfeng Gao,Rui Wang,Xiaojun Wang,Hao Wu,Yang Wang,Xiaofan Lu,Li Li,Jiasheng Zheng,Wei Li

DOI: https://doi.org/10.2217/bmm-2017-0022

Abstract:Aim: Vitamin D is involved in antiviral/antitumor activities. Its associations to hepatitis B virus (HBV), HIV and hepatocellular carcinoma (HCC) are unclear. Materials & methods: A retrospective study was conducted on 232 chronic hepatitis B (CHB) patients and 72 HIV-infected patients. The correlation between serum 25(OH)D3 and 25 vitamin D receptor single nucleotide polymorphisms to disease progression and interferons were evaluated. Results: The 25(OH)D3 was associated with HBV infection and progression. In HIV, it was linked to treatment responsiveness. In CHB, cirrhotic and HCC patients, it was associated with viral load. Fourteen single nucleotide polymorphisms were related to disease progression in HBV infection. In HCC, IFN-λ levels were associated with 25(OH)D3 levels negatively. Conclusion: Serum vitamin D level and vitamin D receptor genetic polymorphisms are associated with CHB and HIV disease progression and IFN-λs.
The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential

Coplen D Johnson,Christopher M Stevens,Matthew R Bennett,Adam B Litch,Eugenie M Rodrigue,Maria D Quintanilla,Eric Wallace,Massoud Allahyari

DOI: https://doi.org/10.3390/nu16234007

IF: 5.9

2024-11-23

Nutrients

Abstract:Hepatic encephalopathy (HE) is a neuropsychiatric condition frequently associated with cirrhosis and portosystemic shunting (PSS). It imposes a significant clinical and economic burden, with increasing attention toward identifying modifiable factors that could improve outcomes. Emerging evidence suggests that vitamin D deficiency (VDD), prevalent in patients with cirrhosis, may contribute to the development and severity of HE. This review explores the association between VDD and HE by analyzing the underlying pathophysiology, including oxidative stress, ammonia accumulation, and impaired hepatic function. Additionally, we summarize recent studies highlighting the correlation between low serum 25-hydroxy vitamin D (25-OHD) levels and worsening grades of HE. Despite strong observational data, interventional studies on vitamin D (VD) supplementation for HE remains limited. Current evidence suggests that VD's antioxidant properties may alleviate oxidative stress in HE, with potential benefits in mitigating disease severity. Future research should focus on longitudinal studies and randomized controlled trials to evaluate the clinical impact of VD supplementation on HE outcomes and explore VD's role in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) procedures. Understanding the therapeutic potential of VD could lead to improved management strategies for HE and cirrhotic patients at large.
Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto's thyroiditis: A systematic review and meta-analysis

Jiahao Tang,Shuanghong Shan,Fangping Li,Peng Yun

DOI: https://doi.org/10.1097/md.0000000000036759

IF: 1.6

2024-01-10

Medicine

Abstract:Hashimoto's thyroiditis (HT) is the prevailing form of autoimmune thyroiditis and the leading cause of hypothyroidism in iodine-sufficient regions worldwide. [ 1 ] The etiology of HT remains uncertain but is currently attributed to genetic susceptibility and environmental factors, including excessive iodine intake, selenium deficiency, viral infections (such as hepatitis C virus), vitamin D deficiency, and others. [ 1–3 ]

medicine, general & internal
Genetic Association of Vitamin D Receptor Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cirrhosis in the Chinese

Ly Fan,Xq Tu,Y Zhu,L Zhou,T Pfeiffer,R Feltens,W Stoeckert,Rq Zhong

DOI: https://doi.org/10.1111/j.1440-1746.2005.03532.x

2003-01-01

Abstract:Background: Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are two autoimmune diseases of unknown etiology. Genetic factors appear to be involved in the pathogenesis of both diseases. Vitamin D has been shown to exert multiple immunomodulatory effects, which acts through its own receptor (VDR). Polymorphisms of VDR had been implicated in several autoimmune diseases. In the present study, the association between Chinese patients with AIH, PBC and the polymorphisms in exon 2, intron 8 and exon 9 of vitamin D receptor genes was studied.Methods: Four candidate gene loci were investigated in 49 patients with AIH, 58 patients with PBC, and 160 healthy controls. The VDR polymorphisms were assessed by FokI, BsmI, ApaI, and TaqI endonuclease digestion after specific polymerase chain reaction (PCR) amplification.Results: The result show a significant difference in FokI polymorphism between AIH patients and controls (chi(2) = 5.47, P = 0.0 19), and a significant association in BsmI polymorphisms between PBC patients and controls (chi(2) = 6.52, P = 0.01). Furthermore the distribution of FokI, BsmI, ApaI, and TaqI gene types differered between Chinese healthy controls and Caucasian healthy controls.Conclusion: It is suggested that there is a genetic link of VDR polymorphisms to autoimmune liver dieseses such as AIH and PBC in Chinese patients. Further studies are needed to elucidate the mechanisms by which VDR polymorphisms contribute to the lose of immune tolerance in autoimmune diseases. (C) 2004 Blackwell Publishing Asia Pty Ltd.
Vitamin D Controls T Cell Activation: Implication for Causal Association Between Vitamin D Deficiency and Fibrosis in Chronic Hepatitis C

Liang Shen

DOI: https://doi.org/10.1002/hep.23781

2010-01-01

Abstract:Vitamin D deficiency has been proved to be associated with many chronic liver diseases. We read with great interest the recent article by Petta et al.1 in which they reported that low vitamin D serum level is related to severe fibrosis and low response to antiviral therapy in patients with genotype 1 (G1) chronic hepatitis C (CHC). The authors also provided important information that low serum vitamin D levels may possibly result from the reduced cytochrome P27A1 expression in patients with G1 CHC.1 However, further investigations are needed to understand the causal association between vitamin D deficiency and fibrosis in patients with CHC. According to the recent significant finding that vitamin D is crucial to activating the immune defenses,2 I would like to propose that low serum vitamin D level may favor progression of fibrosis in patients with CHC. It was found that the killer cells of the immune system—human T cells—depend on vitamin D in order to be activated. Under the condition of vitamin D deficiency, T cells will not be able to react to and kill foreign pathogens in the body.2 Thus, it is conceivable that a low vitamin D serum level will make T cells remain inactive to hepatitis C virus and aggravate the fibrosis in patients with CHC.1 Moreover, in view of the prevalence of vitamin D deficiency in many chronic liver diseases,3, 4 the finding that vitamin D controls activation of human T cells has important implications for future studies concerning the potential role of vitamin D in the treatment of chronic liver diseases. Liang Shen PhD*, * Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Shandong University of Technology, Zibo, China.
Autoimmune hepatitis: Appraisal of current treatment guidelines

Dhruv Lowe,Savio John

DOI: https://doi.org/10.4254/wjh.v10.i12.911

2018-12-27

World Journal of Hepatology

Abstract:Autoimmune hepatitis affects patients of all ages and gender, across all geographic regions. Although still rare, its incidence and prevalence are increasing. Genetic predisposition conveyed by human leucocyte antigen is a strong risk factor for the disease and may be responsible in part for the wide variation in presentation in different geographic regions. Our understanding of the underlying pathogenic mechanisms is evolving and may lead to development of more targeted immunotherapies. Diagnosis is based on elevated levels of serum aminotransferases, gamma globulins, autoantibodies and characteristic findings on histology. Exclusion of other causes of chronic hepatitis is important. Although undiagnosed disease is associated with poor outcomes, it is readily treatable with timely immunosuppressive therapy in the majority of patients. International guidelines are available to guide management but there exists a disparity in the standard treatment regimens. This minireview aims to review the available guidelines and summarize the key recommendations involved in management of this complex autoimmune disease.
Immunomodulatory Function of Vitamin D and Its Role in Autoimmune Thyroid Disease

Rui Zhao,Wei Zhang,Chenghong Ma,Yaping Zhao,Rong Xiong,Hanmin Wang,Weiwen Chen,Song Guo Zheng

DOI: https://doi.org/10.3389/fimmu.2021.574967

IF: 7.3

2021-02-19

Frontiers in Immunology

Abstract:Vitamin D is one of the most important nutrients required by the human body. It is a steroid hormone that plays an important role in regulating calcium and phosphorus metabolism, and bone health. Epidemiological studies have revealed a close correlation between vitamin D and many common chronic diseases. Additionally, vitamin D has recently been shown to act as an immunomodulatory hormone, and, accordingly, vitamin D deficiency was uncovered as a risk factor for autoimmune thyroid diseases, although the underlying mechanisms are still unknown. It is therefore necessary to disclose the role and mechanism of action of vitamin D in the occurrence and development of autoimmune thyroid diseases. This knowledge will help design intervention and early treatment strategies for patients with autoimmune thyroid diseases who present with low levels of vitamin D.

immunology
Association of vitamin D with functional cure in chronic hepatitis B: Insights from a retrospective cohort study and an intervention study

Peipei Wang,Junjian Chen,Zhipeng Li,Husheng Xiong,Ziying Lei,Dabiao Chen,Ying Zhang,Zhiliang Gao,Zhishuo Mo

DOI: https://doi.org/10.1016/j.clnesp.2024.10.145

Abstract:Background & aim: Functional cure for chronic hepatitis B (CHB) patients can be achieved using nucleos(t)ide analogues (NAs) and pegylated interferon alpha (Peg-IFNα) combination treatment. However, the role of vitamin D in functional cure remains unclear. We aimed to investigate the association between vitamin D levels and functional cure in CHB patients. Methods: A retrospective study was conducted to detect changes in serum 25-hydroxyvitamin D (25(OH)D) levels in 526 CHB patients. Furthermore, an intervention study was conducted on 90 CHB patients with baseline vitamin D insufficiency, and 45 patients were randomly assigned to the control group receiving NAs/Peg-IFNα treatment, whereas the remaining patients were categorized into the vitamin D group (VD group) receiving NAs/Peg-IFNα treatment combined with vitamin D supplementation at 800 IU/day. Results: A retrospective study revealed a progressive elevation in serum 25(OH)D levels throughout the duration of treatment. The cured group displayed significantly higher serum 25(OH)D levels than the uncured group (P = 0.046) at the end of treatment, and the changes in serum 25(OH)D (Δ25(OH)D) levels between the two groups were found to be significantly different (P < 0.0001). In the intervention study, the VD group tended to have an increased functional cure rate (48.0 %) compared with the control group (34.3 %) in the binary logistic regression equation analysis (P = 0.09). Notably, a linear mixed-effects model in the longitudinal analysis indicated a significant impact of serum 25(OH)D levels on treatment outcomes (P = 0.017). Conclusions: Serum 25(OH)D and Δ25(OH)D were both positively associated with functional cure in this retrospective study, and vitamin D supplementation may be helpful for functional cure in CHB patients. Registration number of clinical trial: ChiCTR1800020108.
Letter: Association between chronic kidney disease, hepatitis B and antiviral treatments

Chen‐Pi Li,Ru‐Yin Tsai,Hui‐Chin Chang,Shuo‐Yan Gau

DOI: https://doi.org/10.1111/apt.17851

IF: 9.524

2024-01-22

Alimentary Pharmacology & Therapeutics

Abstract:Alimentary Pharmacology &Therapeutics, Volume 59, Issue 4, Page 587-587, February 2024.

pharmacology & pharmacy,gastroenterology & hepatology

Letter: Vitamin D Deficiency and Autoimmune Hepatitis – from Research to Treatment

Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?

Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective

The relationship between 25 hydroxyvitamin D level and chronic hepatitis C: a Meta-analysis

Letter: Autoimmune hepatitis and metabolic syndrome‐associated disease development – a US cohort study

Potential Role of Vitamin D in Immune Response in Patients with Viral Hepatitis.

Vitamin D in liver diseases: from mechanisms to clinical trials.

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.

New Insight of Vitamin D in Chronic Liver Diseases

Vitamin D Receptor Targets Hepatocyte Nuclear Factor 4α and Mediates Protective Effects of Vitamin D in Nonalcoholic Fatty Liver Disease.

Autoimmune Thyroiditis and Vitamin D

Letter: time to consider Pneumocystis jirovecii pneumonia prophylaxis in treatment of autoimmune hepatitis

Vitamin D serum levels and receptor genetic polymorphisms are associated with hepatitis B virus and HIV infections and IFN-λ levels

The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential

Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto's thyroiditis: A systematic review and meta-analysis

Genetic Association of Vitamin D Receptor Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cirrhosis in the Chinese

Vitamin D Controls T Cell Activation: Implication for Causal Association Between Vitamin D Deficiency and Fibrosis in Chronic Hepatitis C

Autoimmune hepatitis: Appraisal of current treatment guidelines

Immunomodulatory Function of Vitamin D and Its Role in Autoimmune Thyroid Disease

Association of vitamin D with functional cure in chronic hepatitis B: Insights from a retrospective cohort study and an intervention study

Letter: Association between chronic kidney disease, hepatitis B and antiviral treatments